Com. v. Tarapchak, S.

CourtSuperior Court of Pennsylvania
DecidedJune 23, 2020
Docket281 MDA 2018
StatusUnpublished

This text of Com. v. Tarapchak, S. (Com. v. Tarapchak, S.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Com. v. Tarapchak, S., (Pa. Ct. App. 2020).

Opinion

J-S17021-20

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37

COMMONWEALTH OF PENNSYLVANIA IN THE SUPERIOR COURT OF PENNSYLVANIA Appellee

v.

STEPHANIE TARAPCHAK

Appellant No. 281 MDA 2018

Appeal from the Judgment of Sentence Entered March 10, 2016 In the Court of Common Pleas of Lackawanna County Criminal Division at No.: CP-35-CR-0000550-2014

BEFORE: PANELLA, P.J., STABILE, J., and FORD ELLIOTT, P.J.E.

MEMORANDUM BY STABILE, J.: FILED JUNE 23, 2020

Appellant Stephanie Tarapchak appeals nunc pro tunc from the March

10, 2016 judgment of sentence entered in the Court of Common Pleas of

Lackawanna County (“trial court”), following her jury convictions for insurance

fraud, theft by deception, corrupt organizations, perjury, endangering the

welfare of children (“EWOC”), drug delivery resulting in death, distributing

prescription to drug dependent person, and refusal or failure to keep records.1

Upon review, we affirm.

The facts and procedural history of this case are undisputed.2 Appellant

operated a small internal medicine practice in Ashland, Pennsylvania. She ____________________________________________

118 Pa.C.S.A. §§ 4117(a)(2), 3922(a)(1), 911(b)(2), 4902(a), 4304(a)(1), 2506(a), and 35 P.S. § 780-113(a)(13), (21), respectively. 2Unless otherwise specified, these facts come from the trial court’s July 17, 2019 opinion. See Trial Court Opinion, 7/17/19, at 3-6, 27-30, 42-43, 51- 53. J-S17021-20

became the focus of an extensive narcotics and drug diversion investigation,

which led to an audit of her DEA, license, including prescription orders,

practices, and dispensation in January 2008 through February 2012, spanning

three Pennsylvania counties, Lackawanna, Luzerne, and Schuylkill.

Concomitantly, Appellant prescribed and dispensed excessive amounts of

narcotics to her paramour, Delton Bolton, as well as her minor child, F.T.,

whereby Appellant became engaged in a hostile custody dispute with her ex-

husband, Alex Tarapchak. Additionally, Appellant was investigated in

connection with the fatal drug overdose of Thomas Kromer (the “victim”). On

April 7, 2014, the Office of the Attorney General charged Appellant with, inter

alia, the above-mentioned offenses.

Subsequently, on September 21, 2015, Appellant proceeded to a two-

week jury trial on all of the above-cited criminal offenses. During trial, the

Commonwealth presented thirty-four witnesses and admitted a voluminous

amount of exhibits. With respect to the victim’s death, the Commonwealth

offered the testimony of six witnesses.

First, several witnesses including Deputy Coroner, David Truskowsky,

pharmacy manager Scott Rishel, and pain management expert, Dr. Stephen

Thomas testified that Appellant prescribed Oxycodone to the victim on June

6, 2011. Second, Mr. Rishel, and Dr. Thomas testified that Appellant

prescribed an increased dosage and prescription, which was not in good faith

or in accordance with treatment principles accepted by a responsible segment

of the medical profession in violation of the Controlled Substance, Drug,

-2- J-S17021-20

Device, and Cosmetic Act. Specifically, Dr. Thomas testified that Appellant

failed to comply with the minimal activities outlined by the Pennsylvania Code

for prescribing controlled substances. He noted that Appellant failed to

document any medical decision making regarding the victim throughout his

seven years as her a patient. Dr. Thomas testified that despite Appellant’s

recognition of the victim’s apparent physical susceptibility as an individual,

and apparent misuse/abuse of his opioid prescription, Appellant enhanced the

toxicity of his opioids and did nothing to minimize the fatal effects. Mr. Rishel

testified that the victim’s May 19, 2011 Oxycodone prescription should not

have necessitated a re-fill prior to June 14, 2011. He recalled that on June 6,

2011, Appellant prescribed an increased dosage and a different medication so

as to enable the victim to re-fill his prescription early, and evade insurance

restrictions. He verified that if the victim attempted to re-fill the May 19, 2011

Oxycodone prescription on June 6, 2011, his insurance would have rejected

payment. Importantly, Mr. Rishel explained that if a person seeks to re-fill a

prescription earlier than their supply expiration, then the person must be

ingesting the prescription above the therapeutic range.

Third, forensic pathologist, Dr. Richard Bindie, and pain management

expert, Dr. Thomas, testified that the victim died as a result of using the June

6, 2011 Oxycodone prescription. Dr. Bindle testified within a reasonable

degree of medical certainty that the combined adverse effects of the multiple

drugs in the victim’s system induced depressed respiration and arrhythmia.

Dr. Thomas testified within a reasonable degree of medical certainty that the

-3- J-S17021-20

normal therapeutic concentration of Oxycodone is less than 100 nanograms

per ML and death has been known to occur in susceptible individuals at a level

greater than 200 nanograms ML. In this case, Dr. Thomas noted that the

victim’s urine concentration reflected Oxycodone at 300 nanograms ML, the

highest concentration of any controlled substance within his system at death.

Similar to Dr. Bindie, Dr. Thomas confirmed that the Alprazolam within the

therapeutic range and the Oxycodone in the toxic range acted synergistically

to cause respiratory depression and led to the victim’s death.

Finally, Tracy and David Kuczynski testified that the victim appeared

overmedicated and disheveled. Mrs. Kuczynski noted that Appellant failed to

provide the victim with instructions or safety mechanisms to prevent abuse

and ensure that the victim ingested his prescriptions within the therapeutic

range. Mr. Kuczynski confirmed that Appellant hardly ever examined or

evaluated the victim prior to filling his prescriptions. He also confirmed that

Mr. Kromer re-filled his prescriptions at least seven to ten days earlier than

his supply expiration. Mr. Rishel corroborated that the victim’s May 19, 2011

Oxycodone prescription should have lasted until June 14, 2019. Instead, Mr.

Rishel recalled that Appellant increased the dosage of the victim’s prior

prescription and changed the medication to Oxycodone without Tylenol. He

explained Appellant’s modification enabled an early re-fill, evaded insurance

restrictions, and represented an increase three times the strength of his

previous prescription.

-4- J-S17021-20

Dr. Bindie opined that a patient like the victim, who is predisposed to

arrhythmia and is prescribed opiates will experience adverse effects that could

increase blood pressure or decrease oxygen and lead to cardiac arrest. He

testified that an individual will die from arrhythmia produced by the

combination of all the drugs that were present in the victim’s urine

concentration at death. Lastly, Dr. Thomas testified that the victim lacked a

medical record, lacked regular visitation or examination, yet he obtained

prescriptions from Appellant at an accelerating pace. He observed that

Appellant enabled the victim, a susceptible individual to misuse/abuse his

prescriptions at a continuing and accelerated rate. Dr. Thomas concluded that

Appellant prescribed a toxic dosage of Oxycodone to the victim for an

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Commonwealth v. Hudson
414 A.2d 1381 (Supreme Court of Pennsylvania, 1980)
Commonwealth v. Cousar
928 A.2d 1025 (Supreme Court of Pennsylvania, 2007)
Commonwealth v. Nunn
947 A.2d 756 (Superior Court of Pennsylvania, 2008)
Commonwealth v. Moury
992 A.2d 162 (Superior Court of Pennsylvania, 2010)
Commonwealth v. Tedford
960 A.2d 1 (Supreme Court of Pennsylvania, 2008)
Commonwealth v. Baumhammers
960 A.2d 59 (Supreme Court of Pennsylvania, 2008)
Commonwealth v. Pressley
887 A.2d 220 (Supreme Court of Pennsylvania, 2005)
Commonwealth v. May
887 A.2d 750 (Supreme Court of Pennsylvania, 2005)
Commonwealth v. Brown
359 A.2d 393 (Supreme Court of Pennsylvania, 1976)
Commonwealth v. Dillon
925 A.2d 131 (Supreme Court of Pennsylvania, 2007)
Commonwealth v. Newman
598 A.2d 275 (Supreme Court of Pennsylvania, 1991)
Commonwealth v. Lewis
598 A.2d 975 (Supreme Court of Pennsylvania, 1991)
Commonwealth v. Ludwig
874 A.2d 623 (Supreme Court of Pennsylvania, 2005)
Commonwealth v. Drumheller
808 A.2d 893 (Supreme Court of Pennsylvania, 2002)
Commonwealth v. Bowser
624 A.2d 125 (Superior Court of Pennsylvania, 1993)
Commonwealth v. Long
624 A.2d 200 (Superior Court of Pennsylvania, 1993)
Commonwealth v. Bradfield
508 A.2d 568 (Supreme Court of Pennsylvania, 1986)
Commonwealth v. Williams
936 A.2d 12 (Supreme Court of Pennsylvania, 2007)
Commonwealth v. Possinger
399 A.2d 1077 (Superior Court of Pennsylvania, 1979)
Commonwealth v. Howard
645 A.2d 1300 (Supreme Court of Pennsylvania, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Com. v. Tarapchak, S., Counsel Stack Legal Research, https://law.counselstack.com/opinion/com-v-tarapchak-s-pasuperct-2020.